Lee S K, Yamamoto T, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 10872602 B2, 2015-11-16.
发明人刘建华,陈志强,胡光. "Method for the Synthesis of Clobazam EP Impurity C" [P]. 中国发明专利, 专利号 CN 108134505 B, 授权公告日 2024-12-10.
Patel M V, Roberts E F, Park J H. "A Process for Preparing High-Purity Clobazam EP Impurity C" [P]. US Patent, US 9370025 B2, 2023-02-02.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2012, 2184, 6911-6922.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2014, 413, (1), 5383-5406.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of Clobazam EP Impurity C Using HRMS and NMR". J. Chromatogr. A, 2013, 1942, (2), 3336-3341.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2016, 2428, (1), 7374-7391.